<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Positron Corp — News on 6ix</title>
    <link>https://6ix.com/company/positron-corp</link>
    <description>Latest news and press releases for Positron Corp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 17 Feb 2026 14:25:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/positron-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835af6c78dffbe2df10f3c1.webp</url>
      <title>Positron Corp</title>
      <link>https://6ix.com/company/positron-corp</link>
    </image>
    <item>
      <title>Positron Corporation Secures Multiple PET-CT  Orders from Leading Nuclear Cardiologist Practices</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-multiple-pet-142500853</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-multiple-pet-142500853</guid>
      <pubDate>Tue, 17 Feb 2026 14:25:00 GMT</pubDate>
      <description>Buffalo, NY, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice scanners, along with associated long-term services agreements, to three distinguished nuclear cardiology practices led by nationally recognized physicians specializing in advanced cardiovascular diagnostics and interventional care. These new customer engagements underscore the ado</description>
    </item>
    <item>
      <title>Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-multiple-pet-ct-orders-from-leading-nuclear-cardiologist-practices</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-multiple-pet-ct-orders-from-leading-nuclear-cardiologist-practices</guid>
      <pubDate>Tue, 17 Feb 2026 14:25:00 GMT</pubDate>
      <description>Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices.</description>
    </item>
    <item>
      <title>Positron AI Raises $230 Million Series B at Over $1 Billion Valuation to Scale Energy-Efficient AI Inference</title>
      <link>https://6ix.com/company/positron-corp/news/positron-ai-raises-dollar230-million-series-b-at-over-dollar1-billion-valuation-to-scale-energy-efficient-ai-inference</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-ai-raises-dollar230-million-series-b-at-over-dollar1-billion-valuation-to-scale-energy-efficient-ai-inference</guid>
      <pubDate>Wed, 04 Feb 2026 13:00:00 GMT</pubDate>
      <description>RENO, Nev., February 04, 2026--Positron AI, the leader in energy-efficient AI inference hardware, today announced an oversubscribed $230 million Series B financing at a post-money valuation exceeding $1 billion.</description>
    </item>
    <item>
      <title>Positron Corporation Raises $2 Million to Expand Market Presence and Growth Initiatives</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-raises-2-million-210000595</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-raises-2-million-210000595</guid>
      <pubDate>Tue, 30 Dec 2025 21:00:00 GMT</pubDate>
      <description>Buffalo, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET) and PET-CT imaging systems and clinical support services, is pleased to announce it has accepted $2.0 million in capital in exchange for 1,333,333 shares of the Company’s stock. The proceeds from the financing will be used to accelerate Positron’s commercial expansion and advance key strategic object</description>
    </item>
    <item>
      <title>Positron Corporation Announces Its Transition to a Reporting SEC Company</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-announces-transition-reporting-141900787</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-announces-transition-reporting-141900787</guid>
      <pubDate>Mon, 17 Nov 2025 14:19:00 GMT</pubDate>
      <description>Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become a reporting company with the U.S Securities and Exchange Commission (SEC). The Company filed a Form 10 registration statement with the SEC containing all required financial statements and disclosures and is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended</description>
    </item>
    <item>
      <title>Positron Corporation Enters Industry Partnership Agreement with MedAxiom</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-enters-industry-partnership-131500582</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-enters-industry-partnership-131500582</guid>
      <pubDate>Thu, 02 Oct 2025 13:15:00 GMT</pubDate>
      <description>Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical services is pleased to announce a partnership with MedAxiom, the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is recognized nationwide for its extensive network of physicians, clinicians, and administrators, and for driving innovation</description>
    </item>
    <item>
      <title>Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-wins-innovation-award-131500423</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-wins-innovation-award-131500423</guid>
      <pubDate>Wed, 01 Oct 2025 13:15:00 GMT</pubDate>
      <description>Buffalo, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has won the Innovation Award in the PET-CT Imaging category in the 2025 Medical Device Network Excellence Awards for making a substantial impact on the evolution of PET-CT imaging technology. The company’s latest PET-CT systems have introduced significant advancements in affordability, workflow, and clinical</description>
    </item>
    <item>
      <title>Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-announces-corporate-headquarters-131500654</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-announces-corporate-headquarters-131500654</guid>
      <pubDate>Fri, 22 Aug 2025 13:15:00 GMT</pubDate>
      <description>North Tonawanda, NY, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that the Company had established a new corporate headquarters in the Buffalo-Niagara Falls region, and that its Board of Directors has approved the redomiciling of the Company from Texas to Delaware. Signed under a long-term lease, the new headquarters will house corporate operations and serve as a product sh</description>
    </item>
    <item>
      <title>Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-multi-unit-132100103</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-multi-unit-132100103</guid>
      <pubDate>Wed, 13 Aug 2025 13:21:00 GMT</pubDate>
      <description>Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice scanners to a nationally recognized nuclear cardiology group specializing in advanced cardiovascular diagnostics and interventional care. This substantial multi-unit order underscores the growing demand for Positron’s next-generation PET-CT imaging solutions, which combine c</description>
    </item>
    <item>
      <title>Positron AI Secures $51.6 Million in Oversubscribed Series A to Accelerate Inference-Optimized Hardware</title>
      <link>https://6ix.com/company/positron-corp/news/positron-ai-secures-dollar516-million-in-oversubscribed-series-a-to-accelerate-inference-optimized-hardware</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-ai-secures-dollar516-million-in-oversubscribed-series-a-to-accelerate-inference-optimized-hardware</guid>
      <pubDate>Mon, 28 Jul 2025 15:00:00 GMT</pubDate>
      <description>RENO, Nev., July 28, 2025--Positron AI, the premier company for American-made semiconductors and inference hardware, today announced the close of a $51.6 million oversubscribed Series A funding round, bringing its total capital raised this year to over $75 million. The round was led by Valor Equity Partners, Atreides Management and DFJ Growth. Additional investment came from Flume Ventures, which includes tech icon Scott McNealy, Resilience Reserve, 1517 Fund and Unless.</description>
    </item>
    <item>
      <title>Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-expands-market-presence-131500435</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-expands-market-presence-131500435</guid>
      <pubDate>Thu, 29 May 2025 13:15:00 GMT</pubDate>
      <description>Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale of its NeuSight PET-CT 64-slice scanner to a prominent nuclear cardiologist specializing in advanced cardiovascular diagnostics and interventional care. This latest sale highlights the growing demand for Positron’s PET and PET-CT solutions, which combine cutting-edge technology with comprehensive cl</description>
    </item>
    <item>
      <title>Positron Corporation Secures Agreement to  Sell Four PET-CT Scanners</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-agreement-sell-135100155</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-agreement-sell-135100155</guid>
      <pubDate>Mon, 14 Apr 2025 13:51:00 GMT</pubDate>
      <description>Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical services, is pleased to announce the sale of four PET-CT scanners to a prominent and highly respected provider of advanced cardiovascular diagnostics and treatment. This achievement underscores Positron’s growing role in advancing cardiac imaging and its commitment to de</description>
    </item>
    <item>
      <title>Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-8-million-200000342</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-8-million-200000342</guid>
      <pubDate>Mon, 31 Mar 2025 20:00:00 GMT</pubDate>
      <description>Niagara Falls, NY, March 31, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET) and PET-CT imaging systems and clinical support services, is pleased to announce it has secured $8 million in capital to accelerate its expansion in the PET-CT market and further strengthen its position as a premier provider of advanced imaging technology and services for nuclear cardiology an</description>
    </item>
    <item>
      <title>Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-agreement-three-141500088</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-agreement-three-141500088</guid>
      <pubDate>Thu, 27 Feb 2025 14:15:00 GMT</pubDate>
      <description>Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered an agreement for three NeuSight PET-CT 64-slice scanners under its Prime Rental Program, to a leading cardiovascular diagnostic, management, and treatment practice. Positron’s commitment to collaborating with such leaders in cardiovascular health</description>
    </item>
    <item>
      <title>Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners </title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-announces-sale-of-attrius-pet-and-neusight-pet-ct-scanners</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-announces-sale-of-attrius-pet-and-neusight-pet-ct-scanners</guid>
      <pubDate>Tue, 28 Jan 2025 14:45:05 GMT</pubDate>
      <description>Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners.</description>
    </item>
    <item>
      <title>Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-secures-agreement-to-sell-and-rent-eight-neusight-pet-ct-scanners</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-secures-agreement-to-sell-and-rent-eight-neusight-pet-ct-scanners</guid>
      <pubDate>Fri, 24 Jan 2025 14:00:57 GMT</pubDate>
      <description>Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners.</description>
    </item>
    <item>
      <title>Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-engages-skyline-corporate-communications-group-llc-to-enhance-investor-relations-and-financial-community-outreach</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-engages-skyline-corporate-communications-group-llc-to-enhance-investor-relations-and-financial-community-outreach</guid>
      <pubDate>Mon, 13 Jan 2025 14:15:17 GMT</pubDate>
      <description>Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach.</description>
    </item>
    <item>
      <title>Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-partners-with-upbeat-cardiology-solutions-to-expand-cardiac-pet-ct-offerings</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-partners-with-upbeat-cardiology-solutions-to-expand-cardiac-pet-ct-offerings</guid>
      <pubDate>Thu, 21 Nov 2024 14:30:47 GMT</pubDate>
      <description>Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings.</description>
    </item>
    <item>
      <title>Positron Corporation Launches Prime Rental Program for Pet-Ct Systems</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-launches-prime-rental-program-for-pet-ct-systems</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-launches-prime-rental-program-for-pet-ct-systems</guid>
      <pubDate>Tue, 01 Oct 2024 13:15:06 GMT</pubDate>
      <description>Positron Corporation Launches Prime Rental Program for Pet-Ct Systems.</description>
    </item>
    <item>
      <title>Positron Corporation Announces Sale of NeuSight PET-CT Scanner</title>
      <link>https://6ix.com/company/positron-corp/news/positron-corporation-announces-sale-of-neusight-pet-ct-scanner</link>
      <guid isPermaLink="true">https://6ix.com/company/positron-corp/news/positron-corporation-announces-sale-of-neusight-pet-ct-scanner</guid>
      <pubDate>Mon, 26 Aug 2024 13:02:46 GMT</pubDate>
      <description>Positron Corporation Announces Sale of NeuSight PET-CT Scanner.</description>
    </item>
  </channel>
</rss>